RNS Reach
3 May 2022
Sureserve Group plc
("Sureserve" or the "Group")
Notice of Investor Presentation
Sureserve Group plc, the Social Housing Energy Services Group, is pleased to announce that Peter Smith, Chief Executive Officer, and Sameet Vohra, Chief Financial Officer, will provide a live presentation relating to the Company's Interim Results via the Investor Meet Company platform on Friday 20 May 2022 at 9:00am BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Sureserve Group plc via:
https://www.investormeetcompany.com/sureserve-group-plc/register-investor
Investors who already follow Sureserve Group plc on the Investor Meet Company platform will automatically be invited.
Enquiries
Sureserve Group plc |
|
Peter Smith, Chief Executive Officer | 07590 929431 |
Sameet Vohra, Chief Financial Officer | 07834 740059 |
|
|
Camarco (Financial Public Relations) | 020 3757 4992 |
Ginny Pulbrook |
|
Rosie Driscoll |
|
Toby Strong |
|
|
|
Shore Capital (Nominated Adviser and Broker) | 020 7408 4090 |
Stephane Auton |
|
Daniel Bush |
|
Fiona Conroy |
|
|
|
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.